Literature DB >> 12858831

[Drug related taste disturbances: emphasis on the elderly].

Lidia Arcavi1, Avner Shahar.   

Abstract

BACKGROUND: Taste disturbances are common among the elderly due to physiologic changes, diseases, and medications. As many as 11% of elderly persons using multiple drugs report taste aberrations. The main danger of taste decline and disturbance in the old is food-anhedonia, causing loss of body weight via decreased calorie and nutrient intake. GOALS: To overview drug related taste disturbances emphasizing the elderly.
METHODS: Review of Hebrew and English medical literature.
RESULTS: Taste-disturbances can be divided into hypogeusia [diminished sense of taste], ageusia [absence of taste], and the 2 types of dysgeusia [taste distortion]: aliageusia [food related] and phantogeusia [taste illusions]. The mechanisms by which drugs impair taste are numerous, and may be related to drug chemical structure. The treatment of taste disturbances is empiric and has limited success. Treatments include: shifting drugs within the same class, zinc replacement (proven to enhance taste sensation for sweet, bitter and salty flavors), palliative measures (use of mints, sugarless chewing-gums, and bicarbonate mouthwashes), niacin and vitamin A ameliorate hypo and dysgeusia.
CONCLUSIONS: Disturbed taste sensation is common among the elderly, and should be considered whenever unexplained nutritional decline is present. Scrupulous drug screening is mandatory, and other intervention modalities can be beneficial.

Entities:  

Mesh:

Year:  2003        PMID: 12858831

Source DB:  PubMed          Journal:  Harefuah        ISSN: 0017-7768


  5 in total

1.  Mirtazapine therapy for dysgeusia in an elderly patient.

Authors:  Kalpana P Padala; Cheryl K Hinners; Prasad R Padala
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

2.  Dysgeusia related to urinary obstruction from benign prostatic disease: a case control and qualitative study.

Authors:  R K Mal; M A Birchall
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02       Impact factor: 2.503

3.  [Side effect management of tyrosine kinase inhibitors in urology : Gastrointestinal side effects].

Authors:  V Lieb; M Rink; D Sikic; B Keck
Journal:  Urologe A       Date:  2016-06       Impact factor: 0.639

Review 4.  Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors.

Authors:  Manuela Schmidinger
Journal:  EJC Suppl       Date:  2013-09

Review 5.  The Important Role of Carbohydrates in the Flavor, Function, and Formulation of Oral Nutritional Supplements.

Authors:  Smaro Kokkinidou; Devin Peterson; Tama Bloch; Ashley Bronston
Journal:  Nutrients       Date:  2018-06-08       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.